97163 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons; Interleukins [IL] IL-6
Methods for ameliorating and preventing central nervous system inflammation
#302CD86 ANTAGONIST MULTI-TARGET BINDING PROTEINS
#303STAT3 phosphorylation during graft-versus-host disease
#304Antagonists of IL-6 to raise albumin and/or lower CRP
#305Agents for use in the treatment of retinal inflammation
#306ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ANEMIA
#307BISPECIFIC ANTIBODIES THAT NEUTRALIZE BOTH TNF-ALPHA AND IL-6: NOVEL THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASE
#308Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules
#309IL-17A binding agent and uses thereof
#310COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME
#311Methods of purifying bispecific antibodies
#312Readily isolated bispecific antibodies with native immunoglobulin format
#313ANTIBODIES WITH MODIFIED AFFINITY TO FCRN THAT PROMOTE ANTIGEN CLEARANCE
#314Antibody producing non-human animals
#315Method for producing polypeptide heteromultimer
#316METHOD OF TREATING A PATHOLOGICAL SYNDROME
#317Pen-injector device containing anti-IL-6 antibodies
#318Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide
#319Antibody derivatives
#320Uses of antibodies to interleukin-6 in cancer treatment
#321Antagonists to IL-6 to raise albumin and/or lower CRP
#322BIOMARKERS FOR THE DIAGNOSIS AND THE RESPONSE TO TREATMENT OF PANCREATIC CANCER
#323Oncostatin M receptor antigen binding proteins
#324Anti-IL-6/IL-6R antibodies
#325DOSING REGIMENS USING ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF RHEUMATOID AND PSORIATIC ARTHRITIS
#326Methods for treating sepsis using chimeric and humanized anti-histone antibodies
#327Antagonists of IL-6 to prevent or treat thrombosis
#328Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
#329Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6
#330Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
#331METHODS FOR PRODUCING ANTIBODIES
#332METHODS OF PRODUCING ANTIBODIES IN YEAST
#333Polynucleotides encoding human oncostatin M antibodies
#334Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
#335Anti-IL-6 antibodies for the treatment of oral mucositis
#336Sgp130/Fc dimers
#337Antagonists of IL-6 to prevent or treat thrombosis
#338Antibodies to IL-6 and use thereof
#339BRAIN FUNCTIONAL MAGNETIC RESONANCE ACTIVITY IS ASSOCIATED WITH RESPONSE TO TUMOR NECROSIS FACTOR INHIBITION
#340Dual targeting
#341DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#342Antibodies to IL-6 and use thereof
#343Method of improving patient survivability and quality of life by administering an anti-IL-6 antibody
#344Anti-IL-6 antibody for use in the treatment of cachexia
#345Cell lines
#346Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibody
#347Method of treating sepsis by administering a soluble CD52 glycoprotein
#348Amino acid derivatives
#349Stable, Low Viscosity Antibody Formulation
#350ANTIBODIES TO IL-6 AND THEIR USES
#351Compounds
#352Treating anemia in chronic IL-6 associated diseases using anti-IL-6 antibodies
#353PREVENTIVE OR THERAPEUTIC AGENT FOR SENSITIZED T CELL-MEDIATED DISEASES COMPRISING IL-6 ANTAGONIST AS AN ACTIVE INGREDIENT
#354TARGET TISSUE-SPECIFIC ANTIGEN-BINDING MOLECULE
#355Methods of treating rapidly progressive glomerulonephritis using chimeric and humanized anti-histone H4 antibodies
#356IL-6 binding molecules
#357ANTIBODY RECOGNIZING HUMAN LEUKEMIA INHIBITORY FACTOR (LIF) AND USE OF ANTI-LIF ANTIBODIES IN THE TREATMENT OF DISEASES ASSOCIATED WITH UNWANTED CELL PROLIFERATION
#358Antibodies to IL-6 and use thereof
#359IL-6 antagonists and uses thereof
#360Bispecific antibodies that neutralize both TNF-α and IL-6: novel therapeutic agent for autoimmune disease
#361Repebody for novel interleukin-6 and use thereof
#362Oncostatin M (OSM) antagonists for preventing cancer metastasis and IL-6 related disorders
#363Method of treating cancer
#364Antigen binding proteins to Oncostatin M (OSM)
#365Treatment methods for rheumatoid arthritis
#366COMPOSITIONS AND METHODS FOR INIHIBITING TUMORIGENICITY OF SENESCENT CANCER CELLS INDUCED BY CHEMOTHERAPY
#367Carrier immunoglobulins
#368Carrier immunoglobulins
#369Nucleic acids that encode interleukin-6 receptor binding polypeptides
#370Modified polypeptides for bispecific antibody scaffolds
#371Methods for blocking or reducing binding of interleukin-6 to interleukin-6 receptor
#372Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
#373Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
#374TENASCIN-C AND USE THEREOF IN RHEUMATOID ARTHRITIS
#375Method for treating chronic colitis and systemic sclerosis and for eliciting a protective immune reaction against human IL-6
#376Antibody producing non-human mammals
#377Antibody producing non-human mammals
#378HUMAN ANTI IL-6 ANTIBODIES WITH EXTENDED IN VIVO HALF-LIFE AND THEIR USE IN TREATMENT OF ONCOLOGY, AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES
#379METHODS OF ENHANCING PROTEIN QUALITY AND QUANTITY BY YEAST FED-BATCH FERMENTATION
#380METHODS OF PRODUCING ANTIBODIES IN YEAST
#381Method of treating rheumatoid arthritis with an anti-IL-6R antibody
#382Readily isolated bispecific antibodies with native immunoglobulin format
#383Chimeric and humanized anti-histone antibodies
#384Interleukin-6 receptor binding polypeptides
#385Methods for the generation of multispecific and multivalent antibodies
#386sgp130/Fc dimers for treatment of inflammatory disease
#387ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES
#388Antibodies to interleukin-6
#389Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide
#390Human oncostatin M antibodies
#391Anti-IL-6 antibodies, compositions, methods and uses
#392Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
#393Method of treating hypertension disorder and a pharmaceutical agent
#394Methods for making antibody molecules having specificity for human IL-6
#395Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
#396Antagonists of IL-6 to raise albumin and/or lower CRIP
#397Methods of purifying antibodies
#398Express humanization of antibodies
#399Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
#400Binding proteins having tethered light chains
#401Antibodies to IL-6 and their uses
#402Antigen binding proteins to oncostatin M (OSM)
#403Protein complexes for antigen binding and methods of use
#404Antibodies to IL-6 to inhibit or treat inflammation
#405Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or fever
#406Antagonists of IL-6 to raise albumin and/or lower CRP
#407Antibody producing non-human mammals
#408Antibody recognizing human leukemia inhibitory factor (LIF)
#409Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodies
#410Antagonists of IL-6 to prevent or treat thrombosis
#411Antagonists of IL-6 to prevent or treat thrombosis
#412Multivalent Antibodies
#413Compositions Comprising TNF-alpha and IL-6 Antagonists and Methods of Use Thereof
#414Subcutaneously administrable composition containing anti-IL-6 antibody
#415Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity
#416Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity
#417Anti-IL-6 antibodies
#418Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
#419Biomarker panels for assessing radiation injury and exposure
#420Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies
#421Compounds
#422ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP
#423Antagonists of IL-6 to prevent or treat thrombosis
#424Dual Variable Domain Immunoglobulins and Uses Thereof
#425Method of treating rheumatoid arthritis with an anti-IL-6R antibody
#426METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER
#427USE OF A COMPOUND FOR REDUCING THE BIOLOGICAL EFFECTIVENESS OF IL-6
#428Antibodies to IL-6 and their uses
#429Carrier immunoglobulins
#430Anti-IL-6 antibodies for the treatment of oral mucositis
#431Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists
#432Methods for the generation of multispecific and multivalent antibodies
#433DNA encoding antibody molecules having specificity for human IL-6
#434Method for selecting a single cell expressing a heterogeneous combination of antibodies
#435ANTIBODIES TO IL-6 AND USE THEREOF
#436Culture Method for Obtaining a Clonal Population of Antigen-Specific B Cells
#437Anti-IL-6 antibodies for the treatment of anemia
#438SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
#439HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENOMICE
#440CD86 antagonist multi-target binding proteins
#441ANTI-IL-6 ANTIBODIES,COMPOSITIONS, METHODS AND USES
#442Human Oncostatin M Antibodies and Methods of Use
#443Anti-IL-6 antibodies, compositions, methods and uses
#444Method of treating rheumatoid arthritis with an anti-IL-6R antibody
#445Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases
#446Anti-IL6/IL-6R antibodies
#447Methods of reducing CRP and/or increasing serum albumin in patients in need using IL-6 antibodies of defined epitopic specificity
#448Humanized anti-IL-6 antibodies
#449ANITIGEN-BINDING CONSTRUCTS
#450Methods of Treating and/or Preventing Cell Proliferation Disorders with IL-17 Antagonists
#451Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity
#452Method of treating psoriatic arthritis with an IL-6 receptor antibody
#453Antagonists of IL-6 to raise albumin and/or lower CRP
#454IMMUNOGLOBULINS
#455ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES
#456Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
#457Therapeutic agent for chronic arthritides diseases of childhood-related diseases
#458NOVEL METHODS AND CELL LINES
#459Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
#460Antagonists of IL-6
#461HLA-G COMPOSITIONS AND METHODS OF USE THEREOF
#462ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TO TWO OR MORE ANTIGEN MOLECULES REPEATEDLY
#463Methods of affinity maturing antibodies
#464Method for administering homeopathically potentiated antibodies against mediator of inflammation
#465Methods of treating conditions using anti-IL-6 antibodies
#466Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
#467USE OF AN ANTI-IL6 ANTIBODY TO DECREASE HEPCIDIN IN CANCER PATIENTS
#468Antibodies to interleukin-6
#469Anti-IL-6/IL-6R antibodies and methods of use thereof
#470Readily isolated bispecific antibodies with native immunoglobulin format
#471Method of treating rheumatoid arthritis with an IL-6R antibody
#472Method for the treatment of glomerulonephritis by administering an IL-6 antibody
#473Methods for ameliorating and preventing central nervous system inflammation
#474Antibodies to IL-6 and use thereof
#475Method of treating disorders of the cardiovascular system and a pharmaceutical agent
#476Method of treating a pathological syndrome and a pharmaceutical agent
#477Interleukin-6 receptor binding polypeptides
#478Methods of treating Osteoarthritis with IL-6 Antagonists
#479Method of treating a disorder or condition of viral etiology
#480ANTIBODY FORMULATIONS
#481HEPATOCYTE GROWTH FACTOR RECEPTOR SPLICE VARIANTS AND METHODS OF USING SAME
#482Method for administering homeopathically potentized antibody
#483Methods of treating anemia using anti-IL-antibodies
#484Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
#485Antibody producing non-human mammals
#486Antagonists of IL-6 to prevent or treat thrombosis
#487Humanized anti-IL-6 antibodies
#488Antibodies to IL-6 and use thereof
#489Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor
#490Antibody producing non-human mammals
#491sgp130/Fc dimers
#492Use of a compound for reducing the biological effectiveness of IL-6
#493Human antibodies derived from immunized xenomice
#494Method for promoting muscle regeneration by administering an antibody to the IL-6 receptor
#495Antibodies to IL-6 and their uses
#496Dual variable domain immunoglobulins and uses thereof
#497Dual variable domain immunoglobulins and uses thereof
#498Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
#499Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
#500Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
#501Antagonists of IL-6 to prevent or treat thrombosis
#502Anti-IL-6 antibodies, compositions, methods and uses
#503Antagonists of IL-6 to raise albumin and/or lower CRP
#504Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
#505DP-78-Like Nanobodies
#506Antibodies to oncostatin M receptor
#507Methods of modifying antibodies for purification of bispecific antibodies
#508Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists
#509Methods for suppressing acute rejection of a heart transplant
#510Anti-IL-6 antibody nucleic acid molecules and methods
#511NOVEL RABBIT ANTIBODY HUMANIZATION METHODS AND HUMANIZED RABBIT ANTIBODIES
#512Methods for treating myocardial infarction comprising administering an IL-6 inhibitor
#513Human antibodies derived from immunized xenomice
#514Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis
#515Novel Rabbit Antibody Humanization Methods and Humanized Rabbit Antibodies
#516Antibodies to IL-6 and use thereof
#517METHOD OF USING IL6 ANTAGONISTS WITH PROTEASOME INHIBITORS
#518Anti-IL-6 antibodies, compositions, methods and uses
#519Mesothelioma therapeutic agent
#520SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY
#521Immuno-Adsorbers For Treatment of Inflammations
#522Bispecific antibody targeting a complement factor or complement regulatory protein
#523METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER
#524Materials and methods to increase peptide chain expression
#525Prevention and treatment of sepsis
#526Anti-human IL-6 antibodies
#527Methods and Compositions for Highly Sensitive Detection of Molecules
#528Methods of Treating Osteoarthritis with Il-6 Antagonists
#529Method of treating a pathological syndrome and a pharmaceutical agent
#530Method for treating psoriasis by administering an antibody to interleukin-6 receptor
#531METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER
#532Anti-IL-6 monoclonal antibodies
#533Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
#534Method of treating a pathological syndrome and a pharmaceutical agent
#535Method of treating a pathological syndrome and a pharmaceutical agent
#536Inflammatory mediator antagonists
#537Method of treating a pathological syndrome and a pharmaceutical agent
#538Method of treating a pathological syndrome and a pharmaceutical agent
#539INFLAMMATORY MEDIATOR ANTAGONISTS
#540Anti-IL-6 antibodies, compositions, methods and uses
#541Immunoglobulins
#542Culture method for obtaining a clonal population of antigen-specific B cells
#543Blood VEGF level-lowering agent containing IL-6 antagonist as the active ingredient
#544Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#545Method of treating a pathological syndrome and a pharmaceutical agent
#546Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis
#547Methods of treating cancer comprising administering an interleukin-6 antibody variable region
#548Antibody molecules having specificity for human IL-6
#549Therapeutic agent for chronic arthritides diseases of childhood-related diseases
#550Mesothelioma therapeutic agent
#551Combination Therapy Of Respiratory Diseases Using Antibodies
#552Use of a compound for reducing the biological effectiveness of il-6
#553Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#554Blood MMP-3 level-lowering agent comprising IL-6 antagonist as active ingredient
#555Anti-il-6 antibodies, compositions, methods and uses
#556Human antihuman interleukin-6 antibody and fragment of antibody
#557Anti-IL-6 antibodies, compositions, methods and uses
#558Antibodies to oncostatin M receptor
#559Remedy for spinal injury containing interleukin-6 antagonist
#560Method for selecting a single cell expressing a heterogeneous combination of antibodies
#561Method and compositions for immunotherapy of inflammatory and immune-dysregulatory diseases
#562Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
#563Methods of treating a disease mediated by sensitized T cells
#564Inflammatory mediator antagonists
#565Method of prevention and treatment of aging and age-related disorders including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimer's disease and cancer
#566Human antibodies derived from immunized xenomice
#567Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#568Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone
#569Combination therapy of respiratory diseases using antibodies
#570Human antibodies derived from immunized xenomice
#571Receptor for Oncostatin M
#572Anti-angiogenic uses of IL-6 antagonists
#573Assay method to monitor the response of anti-cytokine therapy
#574Generation of xenogeneic antibodies
#575High affinity fusion proteins and therapeutic and diagnostic methods for use
#576Human antibodies derived from immunized xenomice
#577Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease
#578High affinity fusion proteins and therapeutic and diagnostic methods for use
#579Tissue-homing peptide conjugates and methods of use thereof